Plasmodium P25 and P28 Surface Proteins: Potential Transmission-Blocking Vaccines
Authors:
Open Access
- 1 August 2007
- journal article
- review article
- Published by American Society for Microbiology in Eukaryotic Cell
- Vol. 6 (8) , 1260-1265
Abstract
Malaria arises from the infection of red blood cells by pro- tozoan parasites of the genus Plasmodium that are transmitted by anopheline mosquitoes. More than 400 species of Anopheles mosquitoes are known, of which about 40 species are charac- terized as important disease vectors for human malaria trans- mission (29). It is estimated that 300 to 500 million cases of malaria and over 1 million deaths from the disease occur each year (49). The Plasmodium parasite must complete its development in the mosquito before it can be transmitted to the vertebrate host and cause malaria. Each stage of parasite development in the mosquito offers potential targets to interfere with malaria transmission. Development of the malaria parasite in the mos- quito begins when the gametocyte forms of the parasite are picked up by the mosquito in the blood meal from an infected human and quickly develop into extracellular gametes in the mosquito midgut. After fertilization, round zygotes form and transform into banana-shaped ookinetes. The ookinetes are motile and must exit the gut by crossing the peritrophic mem- brane and midgut epithelium. On the basal side of the epithe- lium, surviving ookinetes lodge against the basal lamina and transform into spherical oocysts. In the oocyst, the parasite develops into several thousand sporozoites, which then exit the oocyst and are carried by the hemolymph to the mosquito's salivary glands to infect another host (22). There is ongoing research to develop antiparasite vaccines against each stage of the complicated life cycle of Plasmodium (17, 24). Liver-stage vaccines are intended to reduce infection rates, and asexual-blood-stage vaccines will reduce disease se- verity and the risk of death during infection. Transmission- blocking vaccines would prevent the spread of disease by tar- geting antigens expressed in the mosquito stage on the surfaces of the gametocyte, gamete, zygote, and ookinete forms of the parasite (6, 61). These vaccines induce antibodies in the human host that inhibit parasite development in the mosquito midgut and thereby block parasite transmission to another person. This article reviews the biology and structural knowledge of the Plasmodium P25 and P28 proteins and their contributions to transmission-blocking vaccine development.Keywords
This publication has 72 references indexed in Scilit:
- Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: A strategy for enhancing immunogenicity of malaria vaccine candidatesVaccine, 2007
- Long-lasting and transmission-blocking activity of antibodies toPlasmodium falciparumelicited in mice by protein conjugates of Pfs25Proceedings of the National Academy of Sciences, 2007
- Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complexProceedings of the National Academy of Sciences, 2006
- The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prismsNature Structural & Molecular Biology, 2005
- Plasmodium berghei ookinetes bind to Anopheles gambiae and Drosophila melanogaster annexinsMolecular Microbiology, 2005
- EVALUATION OF PROCEDURES TO DETERMINE ABSOLUTE DENSITY OF PLASMODIUM VIVAX OOKINETESJournal of Parasitology, 2005
- Induction of Plasmodium falciparum Transmission-Blocking Antibodies in Nonhuman Primates by a Combination of DNA and Protein ImmunizationsInfection and Immunity, 2004
- A Region ofPlasmodium falciparumAntigen Pfs25 That Is the Target of Highly Potent Transmission-Blocking AntibodiesInfection and Immunity, 2000
- Crystallization of an intact monoclonal antibody (4B7) against Plasmodium falciparum malaria with peptides from the Pfs25 protein antigenActa Crystallographica Section D Structural Biology, 1994
- Structure and function of epidermal growth factor‐like regions in proteinsFEBS Letters, 1988